Back to top
more

Amgen (AMGN)

(Real Time Quote from BATS)

$274.25 USD

274.25
868,500

+0.71 (0.26%)

Updated Apr 24, 2024 01:54 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for AMGN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Amgen Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 10,944 9,305 8,037 10,647 8,911
Receivables 7,268 5,563 4,895 4,525 4,057
Notes Receivable 0 0 0 0 0
Inventories 9,518 4,930 4,086 3,893 3,584
Other Current Assets 2,602 2,388 2,367 2,079 1,888
Total Current Assets 30,332 22,186 19,385 21,144 18,440
Net Property & Equipment 5,941 5,427 5,184 4,889 4,928
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 51,270 31,609 30,072 31,276 34,116
Deposits & Other Assets 9,611 5,899 6,524 5,639 2,223
Total Assets 97,154 65,121 61,165 62,948 59,707
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1,590 1,572 1,366 1,421 1,371
Current Portion Long-Term Debt 1,443 1,591 87 91 2,953
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 15,359 12,524 10,731 10,141 8,511
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 18,392 15,687 12,184 11,653 12,835
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2,354 0 0 0 606
Convertible Debt 0 0 0 0 0
Long-Term Debt 63,170 37,354 33,222 32,895 26,950
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 7,006 8,419 9,059 8,991 9,643
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 90,922 61,460 54,465 53,539 50,034
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 33,070 32,514 32,096 31,802 31,531
Capital Surplus 0 0 0 0 0
Retained Earnings -26,549 -28,622 -24,600 -21,408 -21,330
Other Equity -289 -231 -796 -985 -528
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 6,232 3,661 6,700 9,409 9,673
Total Liabilities & Shareholder's Equity 97,154 65,121 61,165 62,948 59,707
Total Common Equity 6,232 3,661 6,700 9,409 9,673
Shares Outstanding 535.10 533.50 558.30 582.10 594.10
Book Value Per Share 11.65 6.86 12.00 16.16 16.28

Fiscal Year End for Amgen Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 10,944 34,741 34,248 31,561
Receivables NA 7,268 6,145 5,830 5,736
Notes Receivable NA 0 0 0 0
Inventories NA 9,518 5,026 4,978 5,011
Other Current Assets NA 2,602 2,565 2,324 2,395
Total Current Assets NA 30,332 48,477 47,380 44,703
Net Property & Equipment NA 5,941 5,563 5,532 5,460
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 51,270 28,659 30,164 30,924
Deposits & Other Assets NA 9,611 7,835 7,193 7,633
Total Assets NA 97,154 90,534 90,269 88,720
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 1,590 1,358 1,212 1,320
Current Portion Long-Term Debt NA 1,443 1,428 2,167 834
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 15,359 14,168 13,718 12,061
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 18,392 16,954 17,097 14,215
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 2,354 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 63,170 59,040 59,377 60,761
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 6,884 7,014 8,396
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 90,922 82,878 83,488 83,372
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 33,070 32,753 32,601 32,535
Capital Surplus NA 0 0 0 0
Retained Earnings NA -26,549 -24,971 -25,540 -26,919
Other Equity NA -289 -126 -280 -268
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 6,232 7,656 6,781 5,348
Total Liabilities & Shareholder's Equity NA 97,154 90,534 90,269 88,720
Total Common Equity 0 6,232 7,656 6,781 5,348
Shares Outstanding 535.90 535.10 535.10 534.30 534.30
Book Value Per Share 0.00 11.65 14.31 12.69 10.01